Sofinnova Investments, Inc. Summit Therapeutics Inc. Transaction History
Sofinnova Investments, Inc.
- $1.47 Billion
- Q2 2025
A detailed history of Sofinnova Investments, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 700,000 shares of SMMT stock, worth $12.3 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
700,000Holding current value
$12.3 Million% of portfolio
1.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SMMT
# of Institutions
271Shares Held
90.9MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$591 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$152 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$138 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$70.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$68.4 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.53B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...